Hoppa till innehåll

Investors

Press releases

2026-03-31 08:30 Ortivus AB publishes the Annual Report of 2025 Regulatory Annual
“Together with our customers, we demonstrate the power of our platform and our vision: to save lives, improve efficiency, and increase healthcare capacity through the digitalisation of pre-hospital care.”
Ortivus is enabling increased investment in its growth strategy by further strengthening its financial position with an additional loan of SEK 5 million, following the full utilisation of the SEK 20 million credit facility with Ponderus Invest AB.
2026-02-19 08:30 Ortivus AB: Year-end Report January - December 2025 Regulatory Interim
“We enter 2026 with a strengthened balance sheet, a more efficient organisation, and a portfolio of innovations already making a difference.”
Ponderus Invest AB (“Ponderus”) announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag (“Ortivus” or the “Company”) to transfer all of their shares in Ortivus to Ponderus for SEK 1.22 for each Class A...
Ponderus Invest AB (“Ponderus”) announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag (“Ortivus”) to transfer all of their shares in Ortivus to Ponderus for SEK 1.22 for each Class A share, respectively...
The independent bid committee of Ortivus AB (publ) (“Ortivus” or the “Company”) unanimously recommends that shareholders of Ortivus do not accept the mandatory cash offer submitted by Ponderus Invest AB on 2 December 2025.
2025-12-17 08:30 Ortivus welcomes Minni Raij as new CFO Regulatory
Ortivus is pleased to announce the appointment of Minni Raij as the new Chief Financial Officer (CFO) at Ortivus. Minni brings more than two decades of experience in finance and management. Minni will play a central role in Ortivus’ continued growth...
Ponderus Invest AB (“Ponderus”) announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag (“Ortivus”) to transfer all of their shares in Ortivus to Ponderus for SEK 1.22 per class A share and class B share...
On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus AB (“Ortivus”) in accordance with the Takeover Rules...
“The increased interest we are witnessing in the market and from existing customers, together with the high pace of our product development, gives us a positive outlook for the future.”

Get in touch

Empower your team with smarter solutions

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required